Want to see SG:C8R full AI Analyst Report?
C8R Stock Chart & Stats
S$0.02
<S$0.01(3.70%)
At close: 4:00 PM EST
S$0.02
<S$0.01(3.70%)
Day’s Range― - ―
52-Week RangeS$0.02 - S$0.03
Previous CloseN/A
Volume200.20K
Average Volume (3M)5.70M
Market Cap
S$41.76M
Enterprise ValueS$36.68
Total Cash (Recent Filing)S$698.48M
Total Debt (Recent Filing)S$234.88M
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding1,988,444,000
10 Day Avg. Volume2,600,530
30 Day Avg. Volume5,701,756
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.71
Price to Sales (P/S)2.49
P/FCF Ratio-1.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving LeverageLeverage has moved to a moderate level (debt-to-equity ~0.28 in 2025), which provides the company with greater financial stability and room to manage short-term shocks. This structural buffer supports liquidity and reduces refinancing pressure compared with prior higher leverage periods.
Proven Profitability HistoryThe firm demonstrated strong profitability and growth in 2021–2022, showing the business model can deliver healthy margins and growth when conditions are favorable. This historical track record suggests underlying market/product strengths that could be redeployed in a recovery scenario.
Improving Free Cash Flow TrendFree cash flow became less negative in 2025 versus 2023–2024, indicating early progress in cash generation. While still consuming cash, the move toward smaller negative FCF is a durable improvement that, if continued, will reduce funding needs and support operational continuity over coming quarters.
Bears Say
Material Revenue DeclineA multi-year material decline in revenue erodes scale, reduces pricing leverage, and weakens ability to cover fixed costs. Persistent top-line contraction signals structural demand or competitive issues and makes margin recovery and sustainable profitability more difficult without strategic change.
Negative Gross Profit And MarginsNegative gross profit across recent years means core product costs exceed sales, indicating fundamental pricing or cost-structure problems. This undermines any margin sustainability and requires material operational changes, pricing power restoration, or portfolio shifts to restore viability.
Persistent Negative Operating Cash FlowSustained negative operating cash flow increases reliance on external financing and heightens liquidity risk. Continued cash consumption can force asset disposals, dilution, or higher-cost borrowing, reducing strategic flexibility and increasing the chance that losses will erode the equity base over time.
Jiutian Chemical Group Limited News
C8R FAQ
What was Jiutian Chemical Group Limited’s price range in the past 12 months?
Jiutian Chemical Group Limited lowest share price was S$0.02 and its highest was S$0.03 in the past 12 months.
What is Jiutian Chemical Group Limited’s market cap?
Jiutian Chemical Group Limited’s market cap is S$41.76M.
When is Jiutian Chemical Group Limited’s upcoming earnings report date?
Jiutian Chemical Group Limited’s upcoming earnings report date is Aug 12, 2026 which is in 7 days.
How were Jiutian Chemical Group Limited’s earnings last quarter?
Jiutian Chemical Group Limited released its earnings results on Feb 25, 2026. The company reported -S$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Jiutian Chemical Group Limited overvalued?
According to Wall Street analysts Jiutian Chemical Group Limited’s price is currently Overvalued.
Does Jiutian Chemical Group Limited pay dividends?
Jiutian Chemical Group Limited pays a Notavailable dividend of S$0.012 which represents an annual dividend yield of N/A. See more information on Jiutian Chemical Group Limited dividends here
What is Jiutian Chemical Group Limited’s EPS estimate?
Jiutian Chemical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jiutian Chemical Group Limited have?
Jiutian Chemical Group Limited has 1,988,444,000 shares outstanding.
What happened to Jiutian Chemical Group Limited’s price movement after its last earnings report?
Jiutian Chemical Group Limited reported an EPS of -S$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Jiutian Chemical Group Limited?
Currently, no hedge funds are holding shares in SG:C8R
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Jiutian Chemical Group Limited
Jiutian Chemical Group Limited, established in Singapore in 1994, operates as an investment holding company with its primary chemical manufacturing and sales activities located in the People's Republic of China. The company's product portfolio encompasses Dimethylformamide (DMF), a vital raw material for polyurethane, pharmaceutical, and agrochemical sectors, also serving as an absorbent in electronics, acrylic fiber production, and pharmaceuticals. They also produce Methylamine, an essential organic chemical feedstock widely used across various industries including agricultural chemicals, medicines, fuels, synthetic resins, and leather processing, as well as in chemical fiber solvents, activating agents, and photography. Another offering is Sodium Hydrosulfite, a crystalline powder with applications in water treatment, gas purification, cleaning, stripping, and industrial processes for textiles, leather, food, polymers, and photography. Furthermore, Jiutian supplies industrial and consumable Carbon Dioxide for aerated drinks, tobacco, and vegetable preservation. Advanced products include Oxygen-18, an oxygen isotope critical for producing fluorodeoxyglucose, and Deuterium Depleted Water, known for its use in inhibiting cancer cell growth, alongside industrial methanol. The group is also involved in the sales of derivative chemical products and conducts research and development in isotope technology.
Technical Analysis
China Sunsine Chemical Holdings Ltd.
―
Chemical Industries Far East Ltd.
―
Matex International Limited
―
MegaChem Ltd.
―
AsiaPhos Limited
―